Abstract: Aspects of the present application provide liposomal formulations of cannabinoid extracts. Method of using such formulation, e.g., for the treatment of inflammation are also provided.
Abstract: Provided herein are topical formulations including a cannabinoid and one or more active sunscreen ingredients. Also provided are methods of using the topical formulations.
Type:
Application
Filed:
October 6, 2022
Publication date:
February 2, 2023
Inventors:
Glynn WILSON, Brian JOHN, Richard MILLER
Abstract: Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
Abstract: Provided herein are formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
Type:
Application
Filed:
May 7, 2022
Publication date:
September 1, 2022
Applicants:
Healthaide Inc., Jupiter Wellness, Inc.
Abstract: Methods of converting cannabidiol to ?8-tetrahydrocannabinol or ?9-tetrahydrocannabinol are described. The described methods produce higher yields and higher purity compared to prior art methods.
Type:
Application
Filed:
March 20, 2008
Publication date:
September 11, 2008
Inventors:
G. R. Barrie Webster, Leonard P. Sarna, Raphael Mechoulam
Abstract: Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
Type:
Application
Filed:
May 7, 2022
Publication date:
September 1, 2022
Applicants:
Healthaide Inc., Jupiter Wellness, Inc.
Abstract: A liquid capsule of cannabis, ginseng, and turmeric rhizome oil blend consisting essentially of an oil blend of cannabis oil, turmeric rhizome oil, and ginseng oil in a liquid capsule. There is less than 4 ppm of tetrahydrocannabinol (THC) in the oil blend.
Abstract: Methods of converting cannabidiol to &Dgr;8-tetrahydrocannabinol or &Dgr;9-tetrahydrocannabinol are described. The described methods produce higher yields and higher purity compared to prior art methods.
Type:
Application
Filed:
February 25, 2004
Publication date:
July 22, 2004
Inventors:
G. R. Barrie Webster, Leonard P. Sarna, Raphael Mechoulam
Abstract: A liquid capsule of cannabis, ginseng, and turmeric rhizome oil blend consisting essentially of an oil blend of cannabis oil, turmeric rhizome oil, and ginseng oil in a liquid capsule. There is less than 4 ppm of tetrahydrocannabinol (THC) in the oil blend.
Abstract: Methods of converting cannabidiol to ?8-tetrahydrocannabinol or ?9-tetrahydrocannabinol are described. The described methods produce higher yields and higher purity compared to prior art methods.
Type:
Grant
Filed:
March 7, 2002
Date of Patent:
July 15, 2008
Inventors:
G. R. Barrie Webster, Leonard P. Sarna, Raphael Mechoulam
Abstract: The present invention discloses compositions comprising CBD and several herbal extract and use thereof in treatment of mental disorders such as Attention Deficit Hyperactivity disorder (ADHD) and Post Traumatic Stress Disorder (PTSD).
Abstract: The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
Type:
Application
Filed:
January 8, 2014
Publication date:
December 3, 2015
Inventors:
Raphael MECHOULAM, Antonio Waldo ZUARDI, Flavio Pereira KAPCZINSKI, Jaime Eduardo Cecilio HALLAK, Francisco Silveira GUIMARAES, Jose Alexandre de Souza CRIPPA, Aviva BREUER
Abstract: The present invention discloses compositions comprising CBD and several herbal extracts and powders, and methods for the treatment of anorectal disorders such as hemorrhoids.
Abstract: A molecular structure comprising a single-stranded hyaluronic acid moiety, and a plurality of releasable cannabidiol moieties attached thereto is provided herein, as well as uses and methods of treating a skin conditions using the same.
Type:
Application
Filed:
February 3, 2022
Publication date:
August 4, 2022
Applicants:
Ariel Scientific Innovations Ltd., Biosoft Australia Pty Ltd
Abstract: The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
Type:
Application
Filed:
August 1, 2017
Publication date:
November 16, 2017
Inventors:
Raphael MECHOULAM, Antonio Waldo ZUARDI, Flavio Pereira KAPCZINSKI, Jaime Eduardo Cecilio HALLAK, Francisco Silveira GUIMARAES, Jose Alexandre de Souza CRIPPA, Aviva BREUER
Abstract: The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
Type:
Application
Filed:
August 19, 2016
Publication date:
July 13, 2017
Inventors:
Raphael MECHOULAM, Antonio Waldo ZUARDI, Flavio Pereira KAPCZINSKI, Jaime Eduardo Cecilio HALLAK, Francisco Silveira GUIMARAES, Jose Alexandre de Souza CRIPPA, Aviva BREUER
Abstract: Methods of converting CBD to ?8-THC to ?10-THC to ?6a10a-THC are described and the products disclosed. Various adjustments can be made to the reactions resulting in increased or decreased product and by-product.
Type:
Application
Filed:
August 26, 2021
Publication date:
March 2, 2023
Inventors:
Devin Jay WALL, Alek Enrique VALLE, Alexander William Siegel
Abstract: Compounds of the formula ##STR1## are described wherein X is a C.sup.2-11 -alkyl group, optionally substituted by a protected hydroxy, protected oxo or protected carboxy group.
Abstract: The disclosure provides complexes for desired usage as as chemical groups that enhance delivery of moieties from a buccal setting or from a transdermal patch, where the CBD unexepectely enhances the transmission and availability of actives.